HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles H Adler Selected Research

Psychotic Disorders (Schizoaffective Disorder)

10/2019Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
12/2018Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles H Adler Research Topics

Disease

58Parkinson Disease (Parkinson's Disease)
05/2024 - 02/2002
23Dementia (Dementias)
04/2024 - 07/2009
18Alzheimer Disease (Alzheimer's Disease)
05/2024 - 01/2009
14Synucleinopathies
01/2022 - 11/2012
11Cognitive Dysfunction
12/2023 - 07/2009
8Neurodegenerative Diseases (Neurodegenerative Disease)
04/2024 - 09/2012
8Traumatic Brain Injuries (Traumatic Brain Injury)
03/2024 - 01/2019
8Parkinsonian Disorders (Parkinsonism)
11/2023 - 06/2008
7Disease Progression
12/2023 - 05/2014
7Lewy Body Disease (Lewy Body Dementia)
01/2021 - 04/2008
7Torticollis (Wryneck)
10/2019 - 09/2003
5Dysphonia (Spastic Dysphonia)
12/2023 - 09/2004
5Pain (Aches)
12/2023 - 10/2008
4Inflammation (Inflammations)
02/2024 - 02/2011
4Dystonia (Limb Dystonia)
12/2023 - 01/2002
4Amyloid Plaque
01/2021 - 01/2012
4Tremor (Tremors)
12/2016 - 09/2004
4Deglutition Disorders (Dysphagia)
08/2015 - 06/2012
3Chronic Traumatic Encephalopathy
02/2024 - 01/2021
3COVID-19
01/2022 - 01/2021
3Multiple System Atrophy
09/2021 - 01/2021
2Stroke (Strokes)
01/2024 - 05/2014
2Encephalitis (Encephalitis, Rasmussen)
02/2021 - 01/2017
2Psychotic Disorders (Schizoaffective Disorder)
10/2019 - 12/2018
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2019 - 01/2018
2Ganglion Cysts (Ganglion)
10/2018 - 01/2018
2Dyskinesias (Dyskinesia)
03/2018 - 02/2002
2Movement Disorders (Movement Disorder)
03/2018 - 09/2010
2Restless Legs Syndrome (Restless Legs)
10/2011 - 08/2006
2Myoclonus (Nocturnal Myoclonus)
07/2011 - 09/2010
2Hemifacial Spasm
09/2010 - 07/2007
1Amyloid angiopathy
05/2024
1Neuroinflammatory Diseases
04/2024
1Sleepiness
04/2024
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2023
1Death (Near-Death Experience)
01/2023
1Cerebral Infarction
02/2021
1Hypertension (High Blood Pressure)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Obesity
01/2021
1Heart Failure
01/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2021
1Gliosis
01/2021
1Muscle Cramp (Cramp)
11/2020
1Huntington Disease (Huntington's Disease)
01/2020

Drug/Important Bio-Agent (IBA)

34SynucleinsIBA
02/2024 - 02/2011
28Biomarkers (Surrogate Marker)IBA
02/2024 - 09/2012
12alpha-SynucleinIBA
01/2020 - 06/2008
10Amyloid (Amyloid Fibrils)IBA
01/2024 - 01/2012
8Type A Botulinum Toxins (Botox)FDA Link
10/2019 - 01/2002
7TESIBA
03/2024 - 01/2021
7Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2011
7Dopamine (Intropin)FDA LinkGeneric
01/2021 - 08/2013
6Botulinum Toxins (Botulinum Toxin)IBA
12/2023 - 09/2003
6Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2023 - 04/2008
5Indicators and Reagents (Reagents)IBA
01/2023 - 01/2012
47- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
04/2024 - 01/2019
4florbetapirIBA
10/2023 - 04/2014
3Amyloid beta-PeptidesIBA
05/2024 - 01/2009
3Levodopa (L Dopa)FDA LinkGeneric
05/2024 - 09/2007
3Neurotransmitter Agents (Neurotransmitter)IBA
04/2024 - 07/2009
3Retinaldehyde (Retinal)IBA
11/2020 - 06/2014
2Phosphotransferases (Kinase)IBA
05/2024 - 01/2013
2Leucine (L-Leucine)FDA Link
05/2024 - 01/2018
2incobotulinumtoxinAFDA Link
06/2023 - 11/2015
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2023 - 11/2015
2CytokinesIBA
01/2022 - 01/2015
2Serine (L-Serine)FDA Link
01/2021 - 06/2014
2Antipsychotic Agents (Antipsychotics)IBA
10/2019 - 12/2018
2pimavanserinIBA
10/2019 - 12/2018
2ParaffinIBA
01/2019 - 03/2014
2Formaldehyde (Formol)FDA Link
01/2019 - 03/2014
2Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2018 - 10/2016
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2016 - 01/2013
2Acetylcholine (Acetylcholine Chloride)FDA Link
09/2010 - 07/2009
2Cholinergic Agents (Cholinergics)IBA
09/2010 - 07/2009
2rimabotulinumtoxinBFDA Link
07/2007 - 09/2004
1leukocyte-associated immunoglobulin-like receptor 1IBA
04/2024
1RNA (Ribonucleic Acid)IBA
04/2024
1PPAR alphaIBA
04/2024
1C-Reactive ProteinIBA
02/2024
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024
1InterleukinsIBA
02/2024
1Local AnestheticsIBA
12/2023
1Analgesics (Analgesic Drugs)IBA
12/2023
1Apolipoprotein E4IBA
01/2021
1ORALIT (ORS)IBA
01/2021
1RadiopharmaceuticalsIBA
01/2021
1neuromelaninIBA
01/2021
1Hematoxylin (Haematoxylon)IBA
01/2021
1florbenazine F 18IBA
01/2021
1Glial Fibrillary Acidic ProteinIBA
01/2021
1Eosine Yellowish-(YS) (Eosin)IBA
01/2021
1Propranolol (Inderal)FDA LinkGeneric
11/2020

Therapy/Procedure

9Therapeutics
12/2023 - 02/2002
3Injections
12/2023 - 01/2002
3Deep Brain Stimulation
01/2018 - 08/2006
2Denervation
01/2020 - 08/2013